SURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study)
Journal of Clinical Medicine · 30.07.2024 · 13 (15) · 4471
DOI: 10.3390/jcm13154471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 30.07.2024. Verfasst von Antonio Giovanni Cammardella und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery and Heart Transplantation, San Camillo Forlanini Hospital, 00152 Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The transfemoral (TF) approach is the most common route in TAVI, but it is still associated with a risk of bleeding and vascular complications. The aim of this study was to compare the clinical outcomes between surgical cut-down (SC) and percutaneous (PC) approach. (2)
Methods
Between January 2018 and June 2022, 774 patients underwent a transfemoral TAVI procedure. After propensity matching, 323 patients underwent TAVI in each group. (3)
Results
In the matched population, 15 patients (4.6%) in the SC group vs. 34 patients in the PC group (11%) experienced minor vascular complications (p = 0.02), while no difference for major vascular complication (1.5% vs. 1.9%) were reported. The rate of minor bleeding events was higher in the percutaneous group (11% vs. 3.1%, p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery and Heart Transplantation, San Camillo Forlanini Hospital, 00152 Rome, Italy.
- Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands.
- Department of Cardiothoracic Surgery, IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano, 20122 Milano, Italy.
- Department of Cardiothoracic Surgery, Azienda Ospedaliera Papardo, 98158 Messina, Italy.
- Cardiac Surgery, Klinikum Nürnberg-Paracelsus Medical University, 90471 Nuremberg, Germany.
- Department of Biomedical and Clinical Sciences, Universitá degli Studi di Milano, 20122 Milan, Italy.
ORCID-Profile: Antonio Giovanni Cammardella, Marco Russo, Michele Di Mauro, Fabrizio Ceresa, Francesco Patanè, Francesco Pollari, Fabio Barili
Zitieren
APA
Cammardella, A. G., Russo, M., Di Mauro, M., Romagnoni, C., Ceresa, F., Patanè, F., Gelpi, G., Pollari, F., Barili, F., Parolari, A., Ranocchi, F., & Italian Group for Research and Outcomes in Cardiac Surgery (GIROC) of the Italian Society for Cardiac Surgery (SICCH) (2024). SURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study). Journal of Clinical Medicine, 13(15), 4471. https://doi.org/10.3390/jcm13154471
Vancouver
Cammardella AG, Russo M, Di Mauro M, Romagnoni C, Ceresa F, Patanè F, et al. SURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study). Journal of Clinical Medicine. 2024;13(15):4471. doi:10.3390/jcm13154471
BibTeX
@article{Cammardella2024,
author = {Cammardella, Antonio Giovanni and Russo, Marco and Di Mauro, Michele and Romagnoni, Claudia and Ceresa, Fabrizio and Patanè, Francesco and Gelpi, Guido and Pollari, Francesco and Barili, Fabio and Parolari, Alessandro and Ranocchi, Federico and Italian Group for Research and Outcomes in Cardiac Surgery (GIROC) of the Italian Society for Cardiac Surgery (SICCH), Italian Group for Research and Outcomes in Cardiac Surgery (GIROC) of the Italian Society for Cardiac Surgery (SICCH)},
title = {SURgical vs. PERcutaneous ACCESS in Transfemoral Transcatheter Aortic Valve Implantation (SU-PER-ACCESS Study)},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {15},
pages = {4471},
doi = {10.3390/jcm13154471}
}
EUVIMED